| Literature DB >> 30029445 |
Khaled Murtada1, Fernando de Andrés2, Ángel Ríos1, Mohammed Zougagh3.
Abstract
A simple, rapid, selective and sensitive monitoring method for the simultaneous determination of the widely-prescribed antidepressants agomelatine, bupropion, citalopram, fluoxetine, mirtazapine, paroxetine, trazodone in just a human blood drop is here developed and validated. This methodology is based on the use of lab manufactured poly(styrene-co-divinylbenzene)-coated glass (PS-DVB) blood spot for the extraction of the analytes and their subsequent separation and detection by capillary liquid chromatography-mass spectrometry (CLC-MS). Briefly, 10 mm-side squares were punched out from blood spots collected on glass substrate coated by 10 µg of the PS-DVB polymer and eluted with 1.0 mL of 2.0% acetic acid in methanol. The analytes were then separated and detected in less than 20 min by capillary CLC-MS using a Jupiter 4 µm Proteo 90 Å column and water: acetonitrile (20:80 v/v) and ammonium acetate (5 mM, pH 3.0) as mobile phase. Limit of detection (LOD) ranged from 0.018 to 0.038 µg mL-1, and remarkable precision values for the responses and retention times lower than 5.89% and 1.92% were calculated, respectively. Moreover, accuracy values ranging between 85% and 104% were obtained.Entities:
Keywords: Antidepressants; Blood spot; Capillary liquid chromatography-mass spectrometry; Drug monitoring; Poly(styrene-co-divinylbenzene)-coated glass
Year: 2018 PMID: 30029445 DOI: 10.1016/j.talanta.2018.06.059
Source DB: PubMed Journal: Talanta ISSN: 0039-9140 Impact factor: 6.057